Thyroxine-induced cardiac hypertrophy: Influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 285, Issue 6 54-6, 2003, Pages

  Hu, L W ^a   Benvenuti, L A ^a   Liberti, E A ^a   Carneiro Ramos, M S ^a   Barreto Chaves, M L M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II receptors; Angiotensin converting enzyme; Cardiac myocytes; Thyroid hormone

Indexed keywords

ENALAPRIL; LOSARTAN; PROPRANOLOL DERIVATIVE; THYROXINE;

ADRENERGIC SYSTEM; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; BODY WEIGHT; CELL REGENERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART MUSCLE CELL; HEART RATE; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HEMODYNAMIC MONITORING; HYPERTHYROIDISM; HYPOTHYROIDISM; INJECTION; MALE; MICROMORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; THYROIDECTOMY;

EID: 0344851910     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00269.2003     Document Type: Article

References (40)

1. Alpert NR and Mulieri LA. Thermomechanical economy of hypertrophied hearts. In: Perspectives in Cardiovascular Research, Myocardial Hypertrophy and Failure, edited by NR Alpert. New York: Raven, 1983, vol. 7, p. 619.
2. Asahi T, Shimabukuro M, Oshiro Y, Yoshida H, and Takasu N. Cilazapril prevents hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats. Thyroid 11: 1009-1015, 2001.
3. Basset A, Blanc J, Messas E, Hagège A, and Elghozi JL. Renin-angiotensin system contribution to cardiac hypertrophy in experimental hyperthyroidism: an echocardiographic study. J Cardiovasc Pharmacol 37: 163-172, 2001.
4. Bilezikian JP and Loeb JN. The influence of hyperthyroidism and hypothyroidism on α- and β-adrenergic receptor systems and adrenergic responsiveness. Endocr Rev 414: 378-387, 1983.
5. Bing RF, Briggs RSJ, Burden AC, Rusell GI, Swales JD, and Thurston H. Reversible hypertension and hypothyroidism: arterial pressure and hormone relationships. Clin Endocrinol (Oxf) 13: 339-342, 1980.
6. Bruckschiegel G, Holmer SR, Jandelelt K, Grimm D, Muders F, Kromer EP, Riegger GAJ, and Schunkert H. Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Hypertension 25: 250-259, 1995.
7. Cooper G, Kent RL, Uboh CE, Thompson EW, and Marino TA. Hemodynamic versus adrenergic control of cat right ventricular hypertrophy. J Clin Invest 75: 1403-1414, 1985.
8. Crawford DC, Chobanian AV, and Brecher P. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res 74: 727-739, 1994.
9. Dostal DE, Hunt RA, Kule CE, Bhat GJ, Karoor V, Mcwhinney CD, and Baker KM. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways. J Mol Cell Cardiol 29: 2893-2902, 1997.
10. Dzau VJ and Hermann HC. Hormonal control of angiotensinogen production. Life Sci 30: 577-584, 1982.
11. Gerdes AM, Moore JA, and Bishop SP. Failure of propanolol to prevent chronic hyperthyroid induced cardiac hypertrophy and multifocal cellular necrosis in the rat. Can J Cardiol 1: 340-345, 1985.
12. Gerdes AM, Moore JA, and JM Hines. Regional changes in myocyte size and number in propanolol-treated hyperthyroid rats. Lab Invest 57: 708-713, 1987.
13. Ichihara A, Kobori H, Miyashita Y, Hayashi M, and Saruta T. Differential effects of thyroid hormone on renin secretion, content, and mRNA in juxtaglomerular cells. Am J Physiol Endocrinol Metab 274: E224-E231, 1998.
14. Junqueira LCU, Cossermelli W, and Brentani R. Differential staining of collagens type I, II, and III by Sirius red polarization microscopy. Arch Histol Jpn 41: 267-274, 1978.
15. Klein I. Thyroxine-induced hypertrophy: time course of development and inhibition by propanolol. Endocrinology 123: 203-210, 1988.
16. Klein I. Thyroid hormone and the cardiovascular system. Am J Med 88: 631-637, 1990.
17. Kobori H, Ichihara A, Miyashita Y, Hayashi M, and Saruta T. Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy. J Endocrinol 160: 43-47, 1999.
18. Kobori H, Ichihara A, Suzuki H, Miyashita Y, Hayashi M, and Saruta T. Thyroid hormone stimulates renin synthesis in rats without involving the sympathetic nervous system. Am J Physiol Endocrinol Metab 272: E227-E232, 1997.
19. Lear W, Ruzicka M, and Leenen FH. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol 273: H641-H646, 1997.
20. Leenen FHH and Harmsen E. Antihypertensive drugs and cardiac trophic mechanisms. J Cardiovasc Pharm 17, Suppl: S50-S57, 1991.
21. Leenen FHH, White R, and Yuan B. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. Am J Physiol Heart Circ Physiol 281: H2410-H2416, 2001.
22. Levey GS and Klein I. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 88: 642-646, 1990.
23. Linz W, Schoelkens BA, and Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens 11: 1325-1350, 1989.
24. Mandarim-De-Lacerda CA. Quantitative Methods in Morphology (1st ed.). Rio de Janeiro: EDUERJ, 1995, p. 72-77.
25. Marchant C, Brown L, and Sernia C. Renin-angiotensin system in thyroid dysfunction in rats. J Cardiovasc Pharmacol 22: 449-455, 1993.
26. αs mRNAs in rat heart as a function of mechanical load and thyroxine intoxication. Cardiovasc Res 27: 231-237, 1993.
27. Morgan HE and Baker KM. Cardiac hypertrophy: mechanical, neural and endocrine dependence. Circulation 83: 13-25, 1991.
28. Pernitsky AN and Anderson JE. Differential effects of 3,5,3′-triiodothyronine on control and mdx myoblasts and fibroblasts: analysis by flow cytometry. Exp Cell Res 15: 214-222, 1996.
29. Prada PO, Okamoto MM, Furukawa LNS, Machado UF, Heimann JC, and Dolnikoff MS. High-or low-salt diet from weaning to adulthood. Hypertension 35: 424-429, 2000.
30. Sanada S, Kitakaze M, Node K, Takashima S, Ogai A, Asanuma H, Sakata Y, Asakura M, Ogita H, Liao Y, Fukushima T, Yamada J, Minamino T, Kuzuya T, and Hori M. Differential subcellular actions of ACE inhibitors and AT1 receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats. Hypertension 38: 404-411, 2001.
31. Sanford CF, Griffin EE, and Wildenthal K. Synthesis and degradation of myocardial protein during the development and regression of thyroxine-induced cardiac hypertrophy in rats. Circ Res 48: 601-611, 1978.
32. Sernia C, Marchant C, Brown L, and Hoey A. Cardiac angiotensin receptors in experimental hyperthyroidism in dogs. Circ Res 27: 423-428, 1993.
33. Siehl D, Chua BHL, Lautensack-Belser N, and Morgan HE. Faster protein and ribosome synthesis in thyroxine-induced hypertrophy of rat heart. Am J Physiol Cell Physiol 248: C309-C319, 1985.
34. Takemoto M, Egashira K, Tomita H, Usui M, Okamoto H, Kitabatake A, Shimokawa H, Sueishi K, and Takeshita A. Chronic angiotensin-converting enzyme inhibition and angiotensin type-1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. Hypertension 31: 1290-1298, 1998.
35. Truex RC. Myocardial cell diameters in primate hearts. Am J Anat 135: 269-280, 1972.
36. Van Liere EJ, Sizemore DA, and J Hunnell. Size of cardiac ventricles in experimental hyperthyroidism in the rat. Proc Soc Exp Biol Med 132: 663-665, 1969.
37. Vliegen HW, Laarse A, Huysman JAN, Wijnvoord EC, Mentar M, Cornelisse CJ, and Eulderink F. Morphometric quantification of myocyte dimensions validated in normal growing rat hearts and applied to hypertrophic human hearts. Cardiovasc Res 21: 352-357, 1987.
38. Weber KT, Sun Y, Tyagi SC, and Cleutjens JP. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26: 279-292, 1994.
39. Yao J and Eghbali M. Decreased collagen gene expression and absence of fibrosis in thyroid hormone-induced myocardial hypertrophy. Responses of cardiac fibroblasts to thyroid hormone in vivo. Circ Res 71: 831-839, 1992.
40. Zierhut W and Zimmer HG. Significance of myocardial α- and β-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res 65: 1417-1425, 1989.